Intuitive Surgical (ISRG) Reports Q4 Earnings: What Key Metrics Have to Say

Financial Performance - Revenue for the quarter ended December 2024 was $2.41 billion, a 25.2% year-over-year increase [1] - EPS for the quarter was$ 2.21, compared to $1.60 a year ago, representing a 38.1% increase [1] - Revenue matched the Zacks Consensus Estimate of$ 2.41 billion, with a surprise of -0.02% [1] - EPS exceeded the consensus estimate of $1.77 by 24.86% [1] Stock Performance - Shares of Intuitive Surgical returned +13.7% over the past month, outperforming the Zacks S&P 500 composite's +2.7% change [3] - The stock currently has a Zacks Rank 3 (Hold), indicating potential performance in line with the broader market [3] Key Metrics - Da Vinci Surgical System Installed Base: 9,902, slightly below the 9,912 average estimate [4] - Total System Units Placed - Total Company: 493, exceeding the 434 average estimate [4] - Total System Units Placed - United States: 284, surpassing the 208 average estimate [4] - Total System Units Placed - Outside of the United States: 209, slightly above the 207 average estimate [4] Revenue Breakdown - Revenue- Product (Instruments and accessories and Systems):$ 2.07 billion, a 27.2% year-over-year increase, exceeding the $1.85 billion estimate [4] - Revenue- Services:$ 347.40 million, a 14.1% year-over-year increase, slightly above the $345.32 million estimate [4] - Revenue- Systems:$ 654.60 million, a 36.3% year-over-year increase, surpassing the $504.39 million estimate [4] - Revenue- Instruments and accessories:$ 1.41 billion, a 23.4% year-over-year increase, exceeding the $1.35 billion estimate [4]